Charles River Laboratories International (CRL) Competitors $159.78 -3.88 (-2.37%) Closing price 07/11/2025 03:58 PM EasternExtended Trading$159.44 -0.33 (-0.21%) As of 07/11/2025 04:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRL vs. ICLR, TECH, IQV, MTD, WAT, ILMN, BIO, BRKR, PACB, and HBIOShould you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Icon (ICLR), Bio-Techne (TECH), IQVIA (IQV), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), and Harvard Bioscience (HBIO). Charles River Laboratories International vs. Its Competitors Icon Bio-Techne IQVIA Mettler-Toledo International Waters Illumina Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Icon (NASDAQ:ICLR) and Charles River Laboratories International (NYSE:CRL) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations. Is ICLR or CRL more profitable? Icon has a net margin of 9.25% compared to Charles River Laboratories International's net margin of -0.66%. Charles River Laboratories International's return on equity of 15.19% beat Icon's return on equity.Company Net Margins Return on Equity Return on Assets Icon9.25% 11.46% 6.49% Charles River Laboratories International -0.66%15.19%6.93% Do insiders and institutionals have more ownership in ICLR or CRL? 95.6% of Icon shares are owned by institutional investors. Comparatively, 98.9% of Charles River Laboratories International shares are owned by institutional investors. 44.0% of Icon shares are owned by company insiders. Comparatively, 1.3% of Charles River Laboratories International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has better valuation and earnings, ICLR or CRL? Icon has higher revenue and earnings than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIcon$8.28B1.47$791.47M$9.1816.40Charles River Laboratories International$4.05B1.94$22.20M-$0.65-245.81 Does the media prefer ICLR or CRL? In the previous week, Charles River Laboratories International had 4 more articles in the media than Icon. MarketBeat recorded 15 mentions for Charles River Laboratories International and 11 mentions for Icon. Charles River Laboratories International's average media sentiment score of 1.14 beat Icon's score of 0.77 indicating that Charles River Laboratories International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Charles River Laboratories International 10 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer ICLR or CRL? Icon presently has a consensus target price of $198.08, suggesting a potential upside of 31.60%. Charles River Laboratories International has a consensus target price of $174.54, suggesting a potential upside of 9.24%. Given Icon's stronger consensus rating and higher possible upside, equities research analysts plainly believe Icon is more favorable than Charles River Laboratories International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Icon 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.60Charles River Laboratories International 1 Sell rating(s) 10 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.25 Which has more volatility & risk, ICLR or CRL? Icon has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500. Comparatively, Charles River Laboratories International has a beta of 1.49, indicating that its stock price is 49% more volatile than the S&P 500. SummaryIcon beats Charles River Laboratories International on 10 of the 17 factors compared between the two stocks. Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRL vs. The Competition Export to ExcelMetricCharles River Laboratories InternationalMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$8.04B$7.31B$5.61B$20.79BDividend YieldN/A2.81%5.24%3.71%P/E Ratio-245.8133.1327.9627.89Price / Sales1.9435.55430.8942.50Price / Cash7.5423.3737.4622.63Price / Book2.366.858.044.57Net Income$22.20M$230.16M$3.18B$988.81M7 Day Performance1.69%0.01%3.68%0.20%1 Month Performance5.15%0.25%4.10%3.93%1 Year Performance-26.10%33.80%29.59%10.27% Charles River Laboratories International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRLCharles River Laboratories International4.5493 of 5 stars$159.78-2.4%$174.54+9.2%-24.2%$8.04B$4.05B-245.8120,100Positive NewsAnalyst UpgradeICLRIcon4.4601 of 5 stars$147.59-1.7%$213.08+44.4%-55.0%$11.92B$8.19B16.0841,900News CoverageAnalyst ForecastAnalyst RevisionGap DownTECHBio-Techne4.8852 of 5 stars$51.53-3.0%$72.00+39.7%-29.1%$8.08B$1.16B62.843,100Analyst ForecastIQVIQVIA4.8739 of 5 stars$162.57-1.0%$226.32+39.2%-25.8%$28.12B$15.41B22.1588,000Analyst ForecastAnalyst RevisionMTDMettler-Toledo International4.1325 of 5 stars$1,188.28-1.7%$1,300.36+9.4%-9.9%$24.69B$3.87B29.6317,300Positive NewsAnalyst ForecastWATWaters4.3624 of 5 stars$346.35-1.1%$388.00+12.0%+17.1%$20.61B$2.96B31.437,600Trending NewsAnalyst ForecastILMNIllumina4.8432 of 5 stars$97.15-3.6%$127.39+31.1%-15.9%$15.38B$4.37B-16.009,030Trending NewsAnalyst ForecastBIOBio-Rad Laboratories4.5901 of 5 stars$247.45-1.6%$324.25+31.0%-12.9%$6.73B$2.57B-3.257,700News CoveragePositive NewsAnalyst RevisionBRKRBruker4.8851 of 5 stars$41.27-2.8%$52.89+28.2%-31.3%$6.25B$3.37B79.3711,396Positive NewsHigh Trading VolumePACBPacific Biosciences of California1.8342 of 5 stars$1.47-8.1%$2.06+40.2%-2.0%$441.13M$152.36M-0.53730Gap DownHBIOHarvard Bioscience4.2433 of 5 stars$0.44-2.2%$3.00+577.2%-86.4%$19.59M$94.14M-0.34490Trending News Related Companies and Tools Related Companies Icon Alternatives Bio-Techne Alternatives IQVIA Alternatives Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CRL) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
